APE1 shRNA-Loaded Cancer Stem Cell-Derived Extracellular Vesicles Reverse Erlotinib Resistance in Non-Small Cell Lung Cancer via the IL-6/STAT3 Signalling

0
308
The authors delineated the mechanistic actions of APE1/IL-6 signalling in Erlotinib resistance of non-small cell lung cancer.
[Clinical and Translational Medicine]
Full Article